| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Interest Income | 172,334 | -12.233% | 196,354 | 236,165 | 250,458 | 269,629 |
| Interest Expense | (29,421) | -27.377% | (40,512) | (49,016) | (52,123) | (51,751) |
| Net Interest Income | 142,913 | -8.296% | 155,842 | 187,149 | 198,335 | 217,878 |
| Other Operating Income | (1,585) | -- | 19,886 | (12,677) | 9,930 | 34,066 |
| Total Operating Income | 141,328 | -19.576% | 175,728 | 174,472 | 208,265 | 251,944 |
| Net Insurance Claims Incurred & Movement in Policyholders' Liabilities | 0 | -- | 0 | 0 | 0 | 0 |
| Net Operating Income | 141,328 | -19.576% | 175,728 | 174,472 | 208,265 | 251,944 |
| Operating Expenses | (41,134) | -10.399% | (45,908) | (52,881) | (53,416) | (57,658) |
| Impairment Losses on Loans & Advances | (3,188) | -90.091% | (32,173) | 7,836 | (17,835) | (18,877) |
| Other Impairment Losses | (9,261) | 53.252% | (6,043) | 1,664 | (4,419) | (2,246) |
| Operating Profit / (Loss) | 87,745 | -4.213% | 91,604 | 131,091 | 132,595 | 173,163 |
| Change in FV & Impairment on Inv. Prop. | 0 | -- | 0 | 0 | 0 | 0 |
| Change in FV & Impairment on Others | 0 | -- | 0 | 0 | 0 | 0 |
| Profit / (Loss) on Disposal | 0 | -- | 0 | 0 | 0 | 0 |
| Other Non-operating Items | 0 | -- | 0 | 0 | 0 | 0 |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 |
| Profit / (Loss) before Taxation | 87,745 | -4.213% | 91,604 | 131,091 | 132,595 | 173,163 |
| Taxation | (25,499) | -2.702% | (26,207) | (34,455) | (35,899) | (45,465) |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- |
| Non-controlling Interests | (1,804) | -38.992% | (2,957) | (3,986) | (3,356) | (11,209) |
| Others | -- | -- | -- | -- | -- | -- |
| Profit / (Loss) Attributable to Shareholders | 60,442 | -3.200% | 62,440 | 92,650 | 93,340 | 116,489 |
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Depreciation & Amortisation | 5,095 | -1.279% | 5,161 | 6,276 | 8,131 | 8,249 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2025/12 - Final | %Chg (Compare to Final) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
| 2025/12 - Final | %Chg (Compare to Final) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| EPS (cts) | 5.000 | 0.000% | 5.000 | 8.000 | 8.000 | 10.000 |
| DPS (cts) | 0.000 | -- | 1.270 | 2.000 | 4.000 | 5.000 |
| Dividend Payout Ratio (%) | -- | -- | 25.400% | 25.000% | 50.000% | 50.000% |
| Cash flow per share ($) | 0.114 | -- | 0.136 | 0.241 | (0.005) | 0.060 |
| NBV per share ($) | 1.721 | -- | 1.681 | 1.648 | 1.609 | 1.580 |
| Remarks: | Real time quote last updated: 27/03/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 60,442 |
| %Change | -3.200% |
| EPS / (LPS) | RMB 0.050 |
| NBV Per Share (¥) | RMB 1.721 |